This contract expires in 49 days (Oct 31, 2026).
OPTUM INFUSION SERVICES 308, LLC - AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS
Key Details
Description
AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS
Context & Analysis
On Jan 22, 2026, Department of Veterans Affairs obligated $225,000 to OPTUM INFUSION SERVICES 308, LLC for amarillo va pharmacy compounding for oncology medications. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap. Performance is located in AMARILLO, TX. The contract is scheduled through Oct 31, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.